The impact of Covid-19 in patients with chronic myeloid leukemia-a nationwide population-based study

Affiliations

• ¹ Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden. torsten.dahlen@ki.se.
• ² Department of Hematology, Karolinska University Hospital, Stockholm, Sweden. torsten.dahlen@ki.se.
• ³ Department of Medical Science and Division of Hematology, University Hospital, Uppsala, Sweden.
• ⁴ Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
• ⁵ Section of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden.
• ⁶ Department of Hematology, Linköping University Hospital, Linköping, Sweden.
• ⁷ Department of Public Health and Clinical Medicine, Umeå University, Sundsvall, Sweden.
• ⁸ Department of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden.
• ⁹ Department of Microbiology and Immunology, Institute of Biomedicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
• ¹⁰ Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
• ¹¹ Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
• ¹² School of Public health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
• ¹³ Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.